Related references
Note: Only part of the references are listed.Reverse engineering Lewy bodies: how far have we come and how far can we go?
Mohamed Bilal Fares et al.
NATURE REVIEWS NEUROSCIENCE (2021)
Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeys
Yunlong Tao et al.
NATURE MEDICINE (2021)
Viral Delivery of GDNF Promotes Functional Integration of Human Stem Cell Grafts in Parkinson's Disease
Carlos W. Gantner et al.
CELL STEM CELL (2020)
Advantages and Recent Developments of Autologous Cell Therapy for Parkinson's Disease Patients
Teresia M. Osborn et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease
Jeffrey S. Schweitzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD
Deirdre B. Hoban et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease
Daisuke Doi et al.
NATURE COMMUNICATIONS (2020)
Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson's Disease and Adverse Effects of L-DOPA
Ana Munoz et al.
FRONTIERS IN NEUROANATOMY (2020)
iPS cell-based therapy for Parkinson's disease: A Kyoto trial
Jun Takahashi
Regenerative Therapy (2020)
Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson's disease
C. Warren Olanow et al.
BRAIN (2019)
Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease
Roger A. Barker et al.
NATURE MEDICINE (2019)
Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy
Jia-Zhen Wu et al.
TRANSLATIONAL NEURODEGENERATION (2019)
Taking a closer look at PD pathology
Darran Yates
NATURE REVIEWS NEUROSCIENCE (2019)
Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA gene
Yixi Chen et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
Preparing for first human trial of induced pluripotent stem cell-derived cells for Parkinson's disease: an interview with Jun Takahashi
Jun Takahashi
REGENERATIVE MEDICINE (2019)
Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity
Matthew J. Benskey et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts
Alberto J. Espay et al.
ANNALS OF NEUROLOGY (2018)
Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration
Michel Goedert et al.
BRAIN (2017)
Therapeutic potential of autophagy-enhancing agents in Parkinson's disease
Tim E. Moors et al.
MOLECULAR NEURODEGENERATION (2017)
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model
Tetsuhiro Kikuchi et al.
NATURE (2017)
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Yvette C. Wong et al.
NATURE MEDICINE (2017)
Modulating membrane binding of α-synuclein as a therapeutic strategy
Andre Pineda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Replacing Dopamine Neurons in Parkinson's Disease: How did it happen?
Anders Bjorklund et al.
JOURNAL OF PARKINSONS DISEASE (2017)
Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient
Jeffrey H. Kordower et al.
ANNALS OF NEUROLOGY (2017)
Like prions: the propagation of aggregated tau and alpha-synuclein in neurodegeneration
Michel Goedert et al.
BRAIN (2017)
Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain
Erica L. Beatman et al.
JOURNAL OF VIROLOGY (2016)
New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation
Matthias Waldner et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain
Wen Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Successful Function of Autologous iPSC-Derived Dopamine Neurons following Transplantation in a Non-Human Primate Model of Parkinson's Disease
Penelope J. Hallett et al.
CELL STEM CELL (2015)
Trophic Factors for Parkinson's Disease: To Live or Let Die
C. Warren Olanow et al.
MOVEMENT DISORDERS (2015)
Cell-based therapies for Parkinson disease-past insights and future potential
Roger A. Barker et al.
NATURE REVIEWS NEUROLOGY (2015)
Human induced pluripotent stem cells in Parkinson's disease: A novel cell source of cell therapy and disease modeling
Wen Li et al.
PROGRESS IN NEUROBIOLOGY (2015)
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Staffan Holmqvist et al.
ACTA NEUROPATHOLOGICA (2014)
Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson's Disease
Shane Grealish et al.
CELL STEM CELL (2014)
A Bacteriophage Capsid Protein Provides a General Amyloid Interaction Motif (GAIM) That Binds and Remodels Misfolded Protein Assemblies
Rajaraman Krishnan et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
The role of protein clearance mechanisms in organismal ageing and age-related diseases
David Vilchez et al.
NATURE COMMUNICATIONS (2014)
Long-Term Health of Dopaminergic Neuron Transplants in Parkinson's Disease Patients
Penelope J. Hallett et al.
CELL REPORTS (2014)
Long-term Clinical Outcome of Fetal Cell Transplantation for Parkinson Disease Two Case Reports
Zinovia Kefalopoulou et al.
JAMA NEUROLOGY (2014)
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease
Jens Wagner et al.
ACTA NEUROPATHOLOGICA (2013)
Cell Therapy for Parkinson's Disease: What Next?
Anders Bjorklund et al.
MOVEMENT DISORDERS (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Sudhakar Raja Subramaniam et al.
PROGRESS IN NEUROBIOLOGY (2013)
Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into Parkinsonian mice
Christopher R. Bye et al.
EXPERIMENTAL NEUROLOGY (2012)
The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia
Walter J. Schulz-Schaeffer
ACTA NEUROPATHOLOGICA (2010)
Lewy body pathology in fetal grafts
Yaping Chu et al.
YEAR IN NEUROLOGY 2 (2010)
Graft-Induced Dyskinesias in Parkinson's Disease: What Is It All About?
Roger A. Barker et al.
CELL STEM CELL (2010)
α-Synuclein impairs macroautophagy: implications for Parkinson's disease
Ashley R. Winslow et al.
JOURNAL OF CELL BIOLOGY (2010)
Structure and Properties of a Complex of α-Synuclein and a Single-Domain Camelid Antibody
Erwin J. De Genst et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and F-18-FDOPA PET Outcomes
Yilong Ma et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
William J. Marks et al.
LANCET NEUROLOGY (2010)
In Vivo RNAi-Mediated α-Synuclein Silencing Induces Nigrostriatal Degeneration
Oleg S. Gorbatyuk et al.
MOLECULAR THERAPY (2010)
Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson's Patients with Neural Transplants
Marios Politis et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
The propagation of prion-like protein inclusions in neurodegenerative diseases
Michel Goedert et al.
TRENDS IN NEUROSCIENCES (2010)
Transplanted Dopaminergic Neurons Develop PD Pathologic Changes: A Second Case Report
Jeffrey H. Kordower et al.
MOVEMENT DISORDERS (2008)
Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years
Ivar Mendez et al.
NATURE MEDICINE (2008)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Jia-Yi Li et al.
NATURE MEDICINE (2008)
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease
Jeffrey H. Kordower et al.
NATURE MEDICINE (2008)
Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease
D. E. Redmond et al.
NEUROBIOLOGY OF DISEASE (2008)
Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson's disease
E. M. Torres et al.
NEUROSCIENCE (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease
P Piccini et al.
BRAIN (2005)
Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease
I Mendez et al.
BRAIN (2005)
Combining neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient
J Karlsson et al.
CELL TRANSPLANTATION (2005)
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
CW Olanow et al.
ANNALS OF NEUROLOGY (2003)
Dyskinesias following neural transplantation in Parkinson's disease
P Hagell et al.
NATURE NEUROSCIENCE (2002)
The GDNF family: Signalling, biological functions and therapeutic value
MS Airaksinen et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study - Report of three cases
I Mendez et al.
JOURNAL OF NEUROSURGERY (2002)
Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease
P Hagell et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration
D Kirik et al.
JOURNAL OF NEUROSCIENCE (2001)
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
P Brundin et al.
BRAIN (2000)
Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease - Report of two cases and technical considerations
I Mendez et al.
JOURNAL OF NEUROSURGERY (2000)
Share Paper
